As advised via Pharmac Tender announcement 30 June 2017 there is to be a change in the listing and future sole supply.

New listing from 1 January 2018

Omeprazole Actavis 10 Cap 10 mg 90             Pharmacode 2524317                   Schedule price $1.98

Omeprazole Actavis 20 Cap 20 mg 90             Pharmacode 2524325                   Schedule price $1.96

Omeprazole Actavis 40 Cap 40 mg 90             Pharmacode 2524333                   Schedule price $3.12

Incumbent brand

Omezol Relief Cap 10 mg 90                               Pharmacode  2383411      Schedule price $2.23

Omezol Relief Cap 20 mg 90                               Pharmacode  2383438      Schedule price $2.91

Omezol Relief Cap 40 mg 90                               Pharmacode  2383446      Schedule price $4.42

Reference pricing will apply to Omezol from 1 March 2018.

We would recommend you continue to purchase the incumbent and we will switch automatically as existing stocks are exhausted.

Benefit of staying with incumbent

You need to consider the benefit of the 3% margin on your bottom line. To change early can and could be costly due to the volumes dispensed.

You simply need to manage your stock so that you have ZERO stock at time of reference pricing being 1 March 2018, unless we have prior notification of price support being provided.

Once again we need your support to ensure stock in the supply chain moves through, to effectively ensure no losses are incurred.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author